Testing Psychosis Phenotypes From Bipolar–Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets

Harrington, 2019 van den Oord, 2018, Successes and challenges in precision medicine in psychiatry, JAMA Psychiatry, 75, 1269, 10.1001/jamapsychiatry.2018.2897 Jutel, 2010, Medically unexplained symptoms and the disease label, Soc Theor Health, 8, 229, 10.1057/sth.2009.21 Rosenberg, 2006, Contested boundaries: Psychiatry, disease, and diagnosis, Perspect Biol Med, 49, 407, 10.1353/pbm.2006.0046 Ivleva, 2013, Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP), Am J Psychiatry, 170, 1285, 10.1176/appi.ajp.2013.13010126 Skudlarski, 2013, Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives, Am J Psychiatry, 170, 886, 10.1176/appi.ajp.2013.12111448 Hudgens-Haney, 2017, Intrinsic neural activity differences among psychotic illnesses, Psychophysiology, 54, 1223, 10.1111/psyp.12875 Hudgens-Haney, 2018, Psychosis subgroups differ in intrinsic neural activity but not task-specific processing, Schizophr Res, 195, 222, 10.1016/j.schres.2017.08.023 Pearlson, 2016, Does biology transcend the symptom-based boundaries of psychosis?, Psychiatr Clin North Am, 39, 165, 10.1016/j.psc.2016.01.001 Clementz, 2016, Identification of distinct psychosis biotypes using brain-based biomarkers, Am J Psychiatry, 173, 373, 10.1176/appi.ajp.2015.14091200 Lencer, 2015, Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study, Schizophr Res, 169, 326, 10.1016/j.schres.2015.09.032 Gottesman, 2003, The endophenotype concept in psychiatry: Etymology and strategic intentions, Am J Psychiatry, 160, 636, 10.1176/appi.ajp.160.4.636 Braff, 2007, Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder, Schizophr Bull, 33, 21, 10.1093/schbul/sbl049 Bijanki, 2015, Effects of age on white matter integrity and negative symptoms in schizophrenia, Schizophr Res, 161, 29, 10.1016/j.schres.2014.05.031 Mennigen, 2019, Positive and general psychopathology associated with specific gray matter reductions in inferior temporal regions in patients with schizophrenia, Schizophr Res, 208, 242, 10.1016/j.schres.2019.02.010 Jacob, 2019, Aberrant activity in conceptual networks underlies N400 deficits and unusual thoughts in schizophrenia, NeuroImage Clin, 24, 101960, 10.1016/j.nicl.2019.101960 Karageorgiou, 2011, Neuropsychological testing and structural magnetic resonance imaging as diagnostic biomarkers early in the course of schizophrenia and related psychoses, Neuroinformatics, 9, 321, 10.1007/s12021-010-9094-6 Salman, 2019, Group ICA for identifying biomarkers in schizophrenia: “Adaptive” networks via spatially constrained ICA show more sensitivity to group differences than spatio-temporal regression, NeuroImage Clin, 22, 101747, 10.1016/j.nicl.2019.101747 Sui, 2018, Multimodal neuromarkers in schizophrenia via cognition-guided MRI fusion, Nat Commun, 9, 3028, 10.1038/s41467-018-05432-w Hare, 2018, Disrupted network cross talk, hippocampal dysfunction and hallucinations in schizophrenia, Schizophr Res, 199, 226, 10.1016/j.schres.2018.03.004 Tomasik, 2016, Neuroimmune biomarkers in schizophrenia, Schizophr Res, 176, 3, 10.1016/j.schres.2014.07.025 Perkovic, 2017, Theranostic Biomarkers for Schizophrenia, Int J Mol Sci, 18, E733, 10.3390/ijms18040733 Min, 2020, Prediction of individual responses to electroconvulsive therapy in patients with schizophrenia: Machine learning analysis of resting-state electroencephalography, Schizophr Res, 216, 147, 10.1016/j.schres.2019.12.012 Hochberger, 2020, Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients, Schizophr Res, 215, 97, 10.1016/j.schres.2019.11.015 Greenwood, 2019, Genome-wide association of endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) Study, JAMA Psychiatry, 76, 1274, 10.1001/jamapsychiatry.2019.2850 Turetsky, 2015, The utility of P300 as a schizophrenia endophenotype and predictive biomarker: Clinical and socio-demographic modulators in COGS-2, Schizophr Res, 163, 53, 10.1016/j.schres.2014.09.024 Hochberger, 2020, Deviation from expected cognitive ability is a core cognitive feature of schizophrenia related to neurophysiologic, clinical and psychosocial functioning, Schizophr Res, 215, 300, 10.1016/j.schres.2019.10.011 Thompson, 2014, The ENIGMA Consortium: Large-scale collaborative analyses of neuroimaging and genetic data, Brain Imaging Behav, 8, 153, 10.1007/s11682-013-9269-5 van Erp, 2018, Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the Enhancing Neuro Imaging Genetics through Meta Analysis (ENIGMA) Consortium, Biol Psychiatry, 84, 644, 10.1016/j.biopsych.2018.04.023 Drysdale, 2017, Resting-state connectivity biomarkers define neurophysiological subtypes of depression, Nat Med, 23, 28, 10.1038/nm.4246 Kapur, 2012, Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?, Mol Psychiatry, 17, 1174, 10.1038/mp.2012.105 Pandurangi, 2020, Inflammation, antipsychotic drugs, and evidence for effectiveness of anti-inflammatory agents in schizophrenia, Curr Top Behav Neurosci, 44, 227, 10.1007/7854_2019_91 2013, Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis, Lancet, 381, 1371, 10.1016/S0140-6736(12)62129-1 2013, Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs, Nat Genet, 45, 984, 10.1038/ng.2711 Gandal, 2018, Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder, Science, 362, 10.1126/science.aat8127 Purcell, 2009, Common polygenic variation contributes to risk of schizophrenia and bipolar disorder, Nature, 460, 748, 10.1038/nature08185 Lichtenstein, 2009, Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study, Lancet, 373, 234, 10.1016/S0140-6736(09)60072-6 Sullivan, 2018, Psychiatric genomics: An update and an agenda, Am J Psychiatry, 175, 15, 10.1176/appi.ajp.2017.17030283 Jablensky, 2012, The disease entity in psychiatry: Fact or fiction?, Epidemiol Psychiatr Sci, 21, 255, 10.1017/S2045796012000339 Tamminga, 2013, Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP), Am J Psychiatry, 170, 1263, 10.1176/appi.ajp.2013.12101339 Tamminga, 2014, Bipolar and schizophrenia network for intermediate phenotypes: Outcomes across the psychosis continuum, Schizophr Bull, 40, S131, 10.1093/schbul/sbt179 Clementz, 2020, Time for change in psychosis research Wilson, 1998 Price, 2017, A wellness study of 108 individuals using personal, dense, dynamic data clouds, Nat Biotechnol, 35, 747, 10.1038/nbt.3870 Ethridge, 2015, Event-related potential and time-frequency endophenotypes for schizophrenia and psychotic bipolar disorder, Biol Psychiatry, 77, 127, 10.1016/j.biopsych.2014.03.032 Hill, 2013, Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: Findings from the Bipolar and Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study, Am J Psychiatry, 170, 1275, 10.1176/appi.ajp.2013.12101298 Ivleva, 2017, Brain structure biomarkers in the psychosis biotypes: Findings from the Bipolar-Schizophrenia Network for Intermediate Phenotypes, Biol Psychiatry, 82, 26, 10.1016/j.biopsych.2016.08.030 Narayanan, 2014, Resting state electroencephalogram oscillatory abnormalities in schizophrenia and psychotic bipolar patients and their relatives from the Bipolar and Schizophrenia Network on Intermediate Phenotypes Study, Biol Psychiatry, 76, 456, 10.1016/j.biopsych.2013.12.008 Keshavan, 2013, Reimagining psychoses: An agnostic approach to diagnosis, Schizophr Res, 146, 10, 10.1016/j.schres.2013.02.022 Montgomery, 1979, A new depression scale designed to be sensitive to change, Br J Psychiatry, 134, 382, 10.1192/bjp.134.4.382 Lancon, 2000, Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS), Schizophr Res, 42, 231, 10.1016/S0920-9964(99)00129-2 Young, 1978, A rating scale for mania: Reliability, validity and sensitivity, Br J Psychiatry, 133, 429, 10.1192/bjp.133.5.429 Birchwood, 1990, The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients, Br J Psychiatry, 157, 853, 10.1192/bjp.157.6.853 Fischer, 2009, Will the Kraepelinian dichotomy survive DSM-V?, Neuropsychopharmacology, 34, 2081, 10.1038/npp.2009.32 2012 Strauss, 1974, The diagnosis and understanding of schizophrenia: Summary and conclusions, Schizophr Bull Winter, 70 Craddock, 2010, The Kraepelinian dichotomy—going, going … but still not gone, Br J Psychiatry, 196, 92, 10.1192/bjp.bp.109.073429 Cuthbert, 2010, Toward new approaches to psychotic disorders: The NIMH Research Domain Criteria project, Schizophr Bull, 36, 1061, 10.1093/schbul/sbq108 Guloksuz, 2018, The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum, Psychol Med, 48, 229, 10.1017/S0033291717001775 2011 Braga, 2019, Commutability of reference and control materials: An essential factor for assuring the quality of measurements in laboratory medicine, Clin Chem Lab Med, 57, 967, 10.1515/cclm-2019-0154 Caudle, 2018, Standardization can accelerate the adoption of pharmacogenomics: Current status and the path forward, Pharmacogenomics, 19, 847, 10.2217/pgs-2018-0028 Vesper, 2016, Current practices and challenges in the standardization and harmonization of clinical laboratory tests, Am J Clin Nutr, 104, 907S, 10.3945/ajcn.115.110387 Keshavan, 2011, Schizophrenia, “just the facts” 6—Moving ahead with the schizophrenia concept: From the elephant to the mouse, Schizophr Res, 127, 3, 10.1016/j.schres.2011.01.011 Hall, 2019, Longitudinal trajectory of early functional recovery in patients with first episode psychosis, Schizophr Res, 209, 234, 10.1016/j.schres.2019.02.003 Kane, 1988, Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine, Arch Gen Psychiatry, 45, 789, 10.1001/archpsyc.1988.01800330013001 Menezes, 2006, A systematic review of longitudinal outcome studies of first-episode psychosis, Psychol Med, 36, 1349, 10.1017/S0033291706007951 Schmitz, 2007, Inconsistency in the relationship between duration of untreated psychosis (DUP) and negative symptoms: Sorting out the problem of heterogeneity, Schizophr Res, 93, 152, 10.1016/j.schres.2007.03.021 Suvisaari, 2018, Is it possible to predict the future in first-episode psychosis?, Front Psychiatry, 9, 580, 10.3389/fpsyt.2018.00580 Green, 1996, What are the functional consequences of neurocognitive deficits in schizophrenia?, Am J Psychiatry, 153, 321, 10.1176/ajp.153.3.321 Hager, 2015, Neuroimaging biomarkers for psychosis, Curr Behav Neurosci Rep, 2015, 1 Kline, 2017, Innovations in first episode psychosis interventions: The case for a “RAISE-Plus” approach, Schizophr Res, 182, 2, 10.1016/j.schres.2017.03.035 Martinuzzi, 2019, Stratification and prediction of remission in first-episode psychosis patients: The OPTiMiSE cohort study, Transl Psychiatry, 9, 20, 10.1038/s41398-018-0366-5 Koutsouleris, 2016, Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: A machine learning approach, Lancet Psychiatry, 3, 935, 10.1016/S2215-0366(16)30171-7 Koutsouleris, 2018, Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: A multimodal, multisite machine learning analysis, JAMA Psychiatry, 75, 1156, 10.1001/jamapsychiatry.2018.2165 Eack, 2009, Cognitive enhancement therapy for early-course schizophrenia: Effects of a two-year randomized controlled trial, Psychiatr Serv, 60, 1468, 10.1176/ps.2009.60.11.1468 Keshavan, 2017, Longitudinal functional brain imaging study in early course schizophrenia before and after cognitive enhancement therapy, NeuroImage, 151, 55, 10.1016/j.neuroimage.2016.11.060 Wykes, 2011, A meta-analysis of cognitive remediation for schizophrenia: Methodology and effect sizes, Am J Psychiatry, 168, 472, 10.1176/appi.ajp.2010.10060855 Wykes, 2011, Thinking about the future cognitive remediation therapy—What works and could we do better?, Schizophr Bull, 37, S80, 10.1093/schbul/sbr064 Keshavan, 2014, Cognitive training in mental disorders: Update and future directions, Am J Psychiatry, 171, 510, 10.1176/appi.ajp.2013.13081075 Adcock, 2009, When top-down meets bottom-up: Auditory training enhances verbal memory in schizophrenia, Schizophr Bull, 35, 1132, 10.1093/schbul/sbp068 Best, 2019, Brief executive function training for individuals with severe mental illness: Effects on EEG synchronization and executive functioning, Schizophr Res, 203, 32, 10.1016/j.schres.2017.08.052 Best, 2019, A randomized controlled trial of executive functioning training compared with perceptual training for schizophrenia spectrum disorders: Effects on neurophysiology, neurocognition, and functioning, Am J Psychiatry, 176, 297, 10.1176/appi.ajp.2018.18070849 Jahshan, 2019, A randomized controlled trial comparing a “bottom-up” and “top-down” approach to cognitive training in schizophrenia, J Psychiatr Res, 109, 118, 10.1016/j.jpsychires.2018.11.027 Perez, 2017, Mismatch negativity is a sensitive and predictive biomarker of perceptual learning during auditory cognitive training in schizophrenia, Neuropsychopharmacology, 42, 2206, 10.1038/npp.2017.25 Medalia, 2019, Impact of baseline early auditory processing on response to cognitive remediation for schizophrenia, Schizophr Res, 208, 397, 10.1016/j.schres.2019.01.012 Clementz, 2008, Normal electrocortical facilitation but abnormal target identification during visual sustained attention in schizophrenia, J Neurosci, 28, 13411, 10.1523/JNEUROSCI.4095-08.2008 Ethridge, 2011, Sustained versus transient brain responses in schizophrenia: The role of intrinsic neural activity, Schizophr Res, 133, 106, 10.1016/j.schres.2011.07.016 Krishnan, 2005, Steady state visual evoked potential abnormalities in schizophrenia, Clin Neurophysiol, 116, 614, 10.1016/j.clinph.2004.09.016 Rolls, 2008, Computational models of schizophrenia and dopamine modulation in the prefrontal cortex, Nat Rev Neurosci, 9, 696, 10.1038/nrn2462 Thomas, 2019, Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium, Biomark Neuropsychiatry, 1, 100002, 10.1016/j.bionps.2019.100002 Hamm, 2017, Altered cortical ensembles in mouse models of schizophrenia, Neuron, 94, 153, 10.1016/j.neuron.2017.03.019 Hamm, 2016, Somatostatin interneurons control a key component of mismatch negativity in mouse visual cortex, Cell Rep, 16, 597, 10.1016/j.celrep.2016.06.037 Tandon, 2010, Schizophrenia, “just the facts” 5—Treatment and prevention: Past, present, and future, Schizophr Res, 122, 1, 10.1016/j.schres.2010.05.025 Masuda, 2019, Association with hospitalization and all-cause discontinuation among patients with schizophrenia on clozapine vs other oral second-generation antipsychotics: A systematic review and meta-analysis of cohort studies, JAMA Psychiatry, 76, 1052, 10.1001/jamapsychiatry.2019.1702 Coward, 1992, General pharmacology of clozapine, Br J Psychiatry, 160, 5, 10.1192/S0007125000296840 Knott, 2001, Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment, Schizophr Res, 50, 41, 10.1016/S0920-9964(00)00165-1 Gross, 2004, Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: A prospective, longitudinal study, Pharmacopsychiatry, 37, 119, 10.1055/s-2004-818989 Kendell, 2003, Distinguishing between the validity and utility of psychiatric diagnoses, Am J Psychiatry, 160, 4, 10.1176/appi.ajp.160.1.4 Bleuler, 1950 Robins, 1970, Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia, Am J Psychiatry, 126, 983, 10.1176/ajp.126.7.983